Nov 5 (Reuters) – Dr. Reddy's Laboratories Limited : * DR REDDY'S – RECEIVES MARKETING AUTHORIZATION FOR GENERIC SEMAGLUTIDE INJECTION IN BRAZIL Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 5 (Reuters) - Soda Nikka Co Ltd: * TO BUY BACK UP TO 4.37%…
Berlin (dpa) - Mum makes another unannounced visit. For the 10th year in a row,…
By Rocky Swift TOKYO, Nov 5 (Reuters) - The dollar extended its decline on Thursday…
Nov 5 (Reuters) - Microsoft has rejected an option to more than double the size…
By Summer Zhen HONG KONG, Nov 5 (Reuters) - Hong Kong stocks jumped while China…
GS Holdings Corp.: * GS HOLDINGS: Q3 OPERATING PROFIT 1.27 TRLN WON, UP 46.4% FROM…